Corza Medical

Corza Medical is a rapidly scaling, revenue-generating medical device company with a significant global footprint, operating in over 80 countries with more than 3,000 employees and generating over $500 million in revenue. The company leverages a diversified portfolio of surgical products, including sutures, ophthalmic microsurgical tools, and advanced hemostats, targeting hospitals, ASCs, surgeons, and OEM partners. Founded through strategic acquisitions and organic growth, Corza positions itself as a value-driven alternative to large medtech incumbents, emphasizing cost-effectiveness without sacrificing quality. Its recent expansion through facility launches and the acquisition of TachoSil manufacturing operations underscores its aggressive growth strategy in the global surgical supplies market.

Manufacturing and innovation platform for surgical sutures, biomedical textiles, ophthalmic microsurgical devices, and hemostatic agents. Focus on quality manufacturing, cost-effective production, and a dedicated Biomedical Textiles Innovation Lab for OEM partner collaboration.

Corza competes in the crowded surgical supplies market against dominant multinationals like Johnson & Johnson (Ethicon), Medtronic, and Becton Dickinson, as well as numerous other specialized and generic manufacturers. Its strategy is to differentiate through a combination of competitive pricing, reliable quality, and personalized service, targeting cost-conscious hospitals, ASCs, and surgeons.